Study on the Mechanism of Nanomotor Drug Delivery Platform for the Treatment of Periimplantitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400086643

Enrollment

Unknown

Registered

2024-07-08

Start date

2024-03-05

Completion date

Unknown

Last updated

2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periimplantitis

Interventions

Collect saliva secreted by volunteers.:NA

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Have a good health condition, do not smoke, have no caries or periodontal disease, and have not used antibiotics or mouthwash or other oral health products locally or throughout the body for 6 months. 2. Informed consent of the patient.

Exclusion criteria

Exclusion criteria: 1. Patients with poor oral hygiene conditions. 2. Patients with Sjogren's syndrome or other reasons such as salivary gland degeneration leading to reduced salivary secretion.

Design outcomes

Primary

Measure	Time frame
Saliva bacterial content after treatment;	—

Countries

China

Contacts

Public ContactChen Bo

Stomatological Hospital of Tianjin Medical University

chenbo@tmu.edu.cn+86 22 2333 2070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026